Tobacco Treatment TrAining Network in Greece & Cyprus (TiTAN)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03040349|
Recruitment Status : Unknown
Verified January 2017 by Christor Lionis, University of Crete.
Recruitment status was: Not yet recruiting
First Posted : February 2, 2017
Last Update Posted : February 2, 2017
The overall aim of the TiTAN Greece & Cyprus project is to expand the Global Bridges Tobacco Treatment Training Network in the WHO Europe region through a focus on primary health care providers in Greece and Cyprus. A robust evaluation will be conducted alongside the TiTAN program. A pre-post evaluation will be used to examine the impact on the TiTAN program on:
- Provider engagement (number of providers attending training), number of local champions;
- Provider knowledge, beliefs, perceived behavioral control, and intentions related to the delivery of tobacco treatment;
- Rates of evidence-based tobacco treatments (5As) are delivered to patients who smoke;
- Provider satisfaction with training program, resources, and network outreach activity and areas for improvement; and
- Estimates on the impact on patient-level outcomes including number of patient quit smoking at 1 and 3-month follow-up.
All PHC providers will be surveyed before and after the intervention program is delivered. We will randomly select a sub-sample of providers and will survey patients from their practice before and after the intervention program in order to validate changes in 5As delivery. Qualitative interviews will be completed with a sub-sample of providers at the end of year 1.
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Use||Behavioral: Training Behavioral: Provider and Patient Tools Behavioral: E-blast and Webinars||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of the Primary Care Tobacco Treatment TrAining Network in Greece & Cyprus|
|Estimated Study Start Date :||February 2017|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||December 2019|
Experimental: TiTAN Intervention
The TiTAN Crete program has adapted the existing curricula and resources originally developed at the University of Ottawa Heart Institute and which are specific to primary practice settings. To facilitate maximum uptake the intervention program was adapted to reflect: language; cultural appropriateness; local patient beliefs and attitudes regarding tobacco-use and cessation; local social and clinical norms; provider perceptions surrounding 5As delivery; and, practice characteristics. The TiTAN multi-component training includes: 1) a 1-day foundational tobacco treatment training program for general practitioners, 2) the dissemination of provider and patient tools, and 3) E-blasts and webinars to supplement skills development and continuing medical education through e-learning.
The training program consists of a one-day core session addressing tobacco use with patients in the context of a busy primary care practice setting.The curriculum design was designed to be 2/3 theory and 1/3 practical. The program employs teaching techniques including role-play and case-study approaches known to enhance practice change.
Behavioral: Provider and Patient Tools
Provider and patient tools were translated and adapted for use in primary care settings in Greece. A tool kit of resources will be distributed to providers which includes: patient tobacco use survey; provider consult form; provider medication reference sheet; patient quit plan booklet; and, waiting room posters. The provider consult form uses a checklist style set-up and provides real-time reminders for conducting an initial smoking cessation visit and follow-up appointments. The TiTAN Crete tools are available online at www.titan.uoc.gr
Behavioral: E-blast and Webinars
In order to develop the network and continue to provide training opportunities for skills development we will develop a communication platform via an email list-serv to proactively communicate with providers who participate in the TiTAN program. A quarterly e-blast will be sent to all health care professionals involved in the TiTAN program. The e-blast will address the latest evidence-base practice, and skill development. Links to videos will also be provided. A webinar series will be scheduled to cover topics identified as interest by the primary health care providers. The webinar series will also be linked the Global Bridges EPACTT project.
- Provider Performance in the Delivery of Cessation Treatments assessed via patient exit survey [ Time Frame: Change between pre-intervention and post intervention (3-months) ]Performance in the delivery of each of the 5As will be assessed via exit interview with eligible patients. The survey will ask participants to respond either "yes" or "no" or "don't know" regarding whether their PHC provider asked them about their smoking status (ask); advised them to quit smoking (advise); assessed their readiness to quit (assess); provided assistance with quitting (assist); prescribed pharmacotherapy, provided self-help materials, and arranged follow-up support
- Provider Self-efficacy assessed by questionnaire [ Time Frame: Change between pre-intervention and post-training (1-month) ]Provider self-efficacy will be assessed before and after the intervention
- Provider knowledge assessed by questionnaire [ Time Frame: Change between pre-intervention and post intervention (3-months) ]Provider knowledge of evidence-based tobacco treatment guidelines will be assessed using a brief 15-item knowledge assessment to examine key concepts addressed as part of training. The knowledge assessment has been tested as part of the TiTAN Crte project.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03040349
|Contact: Christos Lionisemail@example.com|
|Contact: Sophia Papadakisfirstname.lastname@example.org|
|University of Crete|
|Heraklion, Crete, Greece, 71500|
|Contact: Christos Lionis, MD, PhD email@example.com|
|Contact: Sophia Papadakis, PhD 306982551782 firstname.lastname@example.org|
|Principal Investigator: Christos Lionis, MD, PhD|
|Principal Investigator: Sophia Papadakis, PhD|
|Principal Investigator: Constantine Vardavas, MD, PhD|
|Sub-Investigator: George Samoutis, MD, PhD|
|Sub-Investigator: Andrew Pipe, MD|
|Sub-Investigator: Athina Tatsioni, MD, PhD|
|Sub-Investigator: Emmanuel Smyrnakis, MD, PhD|
|Principal Investigator:||Christos Lionis, MD, PhD||University of Crete|